ID   WEHI-3B
AC   CVCL_2239
SY   WEHI-3b; Wehi-3B; WEHI 3B; WEHI3B; W3(H); WEHI-3 subline B
DR   BTO; BTO:0005282
DR   CLO; CLO_0009569
DR   CLO; CLO_0009580
DR   CLO; CLO_0050196
DR   CLDB; cl4684
DR   CLDB; cl4685
DR   CLDB; cl4686
DR   CLDB; cl4937
DR   BCRJ; 0248
DR   ChEMBL-Cells; CHEMBL3307352
DR   ChEMBL-Targets; CHEMBL614249
DR   CLS; 400376
DR   DSMZ; ACC-26
DR   DSMZCellDive; ACC-26
DR   ECACC; 86013003
DR   IBRC; C10075
DR   ICLC; ATL99003
DR   JCRB; IFO50296
DR   Lonza; 1430
DR   PubChem_Cell_line; CVCL_2239
DR   RCB; RCB2853
DR   TKG; TKG 0584
DR   Wikidata; Q54993761
RX   DOI=10.1016/0165-4608(80)90043-6;
RX   PubMed=3792703;
RX   PubMed=5259325;
RX   PubMed=8343448;
RX   PubMed=17635523;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-3B
CC   Characteristics: Constitutively produces interleukin-3 (IL3).
CC   Doubling time: 20 hours (PubMed=8343448); ~20-30 hours (DSMZ=ACC-26).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
ST   Source(s): DSMZ
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 22.3,23.3,25.3
ST   Mouse STR 18-3: 18
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19,20
ST   Mouse STR 6-7: 12
ST   Mouse STR X-1: 25,26
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3622 ! WEHI-3
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 24
//
RX   DOI=10.1016/0165-4608(80)90043-6;
RA   Bornstein S., McMorrow L.E.;
RT   "Marker chromosomes of WEHI-3, a murine myelomonocytic cell line.";
RL   Cancer Genet. Cytogenet. 1:345-349(1981).
//
RX   PubMed=3792703; DOI=10.1111/j.1432-0436.1986.tb00568.x;
RA   Leenen P.J.M., Jansen A.M.A.C., van Ewijk W.;
RT   "Murine macrophage cell lines can be ordered in a linear
RT   differentiation sequence.";
RL   Differentiation 32:157-164(1986).
//
RX   PubMed=5259325; DOI=10.1093/jnci/43.4.963;
RA   Warner N.L., Moore M.A.S., Metcalf D.;
RT   "A transplantable myelomonocytic leukemia in BALB-c mice: cytology,
RT   karyotype, and muramidase content.";
RL   J. Natl. Cancer Inst. 43:963-982(1969).
//
RX   PubMed=8343448;
RA   Kajigaya Y., Sasaki H., Ikuta K., Matsuyama S., Hirabayashi Y.,
RA   Inoue T.;
RT   "Serum-free culture for leukemia cells.";
RL   Hum. Cell 6:49-56(1993).
//
RX   PubMed=17635523; DOI=10.1111/j.1365-2184.2007.00456.x;
RA   Pessina A., Bonomi A., Casati S., Collotta A., Croera C.,
RA   Marafante E., Palitti F., Gribaldo L.;
RT   "Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B
RT   leukaemia cell line and its variant Ciprofloxacin-resistant
RT   WEHI-3B/CPX.";
RL   Cell Prolif. 40:568-579(2007).
//